Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach (Q33717413)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach |
scientific article |
Statements
1 reference
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach (English)
1 reference
Joseph A Sparano
1 reference
Rhonda K Yantiss
1 reference
Allyson J Ocean
1 reference
Paul Christos
1 reference
Manish A Shah
1 reference
Jonathan Cheng
1 reference
Juan Lin
1 reference
Michael Papetti
1 reference
Dan Matulich
1 reference
Felice Schnoll-Sussman
1 reference
Christen Besanceney-Webler
1 reference
Jenny Xiang
1 reference
Maureen Ward
1 reference
Kaili Temple Dilts
1 reference
Roger Keresztes
1 reference
Shannon Holloway
1 reference
Eric X Chen
1 reference
John J Wright
1 reference
Maureen E Lane
1 reference
15 February 2014
1 reference
1 reference
Identifiers
1 reference